Rienk Offringa

7PUBLICATIONS

33CO-AUTHORS

Tumour immunologyMolecular targetsPredictive and prognostic markersBiologically active moleculesMedical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Apr 10, 2026

Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire.

Hannes Kehm, Stefan Zens, Daniel Baumann

|Jun 03, 2025

Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer.

|Sep 27, 2024

Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer.

Jeffrey Mowat, Rafael Carretero, Gabriele Leder

|Nov 15, 2023

Transcriptome-based identification of tumor-reactive and bystander CD8<sup>+</sup> T cell receptor clonotypes in human pancreatic cancer.

Zibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan

|Aug 18, 2022

The expanding role for small molecules in immuno-oncology.

Rienk Offringa, Lisa Kötzner, Bayard Huck

|Jul 21, 2021

p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition.

Daniel Baumann, Jennifer Drebant, Tanja Hägele

Pageof 2

Frequent Collaborators

Isabel Poschke

Michael Volkmar

Angelika B Riemer

Jonas D Förster

Mogjiborahman Salek

Stefan Zens

Zibo Meng

Chin Leng Tan

Hannes Kehm

Roman Fischer

Frequent Collaborators

Isabel Poschke

Michael Volkmar

Angelika B Riemer

Jonas D Förster